148 results on '"Doranz, Benjamin J."'
Search Results
2. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
3. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
4. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
5. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
6. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
7. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
8. Abstract 2646: Screening the membrane proteome to determine antibody specificity and de-risk CAR-T cell development
9. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
10. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
11. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
12. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
13. Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
14. Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
15. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
16. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
17. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
18. Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
19. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
20. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
21. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
22. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
23. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
24. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
25. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
26. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
27. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
28. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
29. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
30. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition
31. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
32. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
33. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
34. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
35. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
36. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
37. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
38. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
39. A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies
40. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
41. Measuring Membrane Protein Interactions Using Optical Biosensors
42. Convergence of a common solution to broad ebolavirus neutralization by glycan cap directed human antibodies
43. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus within vivotherapeutic potency
44. Abstract 5688: IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology
45. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
46. Integrated technology platform for accelerated discovery of antiviral antibody therapeutics
47. Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus
48. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
49. Abstract A89: Identification of novel costimulatory pathways in T cells with functional assays on the Membrane Proteome Array (MPA)
50. Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.